Group 1 - Yongji Co., Ltd. announced on August 13 that it is planning to acquire control of Nanjing Tenafly Electronics Technology Co., Ltd. through a combination of issuing shares and cash payment, and will raise matching funds by issuing shares to no more than 35 specific investors [1][7] - The transaction may constitute a major asset restructuring but will not lead to a change in the actual controller of the company and does not constitute a restructuring listing [1] - Yongji Co., Ltd. has signed a preliminary acquisition intention agreement with the actual controller of Tenafly, LEE MENG KUN, with the final transaction price to be determined based on audit and evaluation reports [7] Group 2 - Yongji Co., Ltd. has been expanding its business into the social printing market, including cigarette labels, liquor packaging, and pharmaceutical packaging, while also exploring the overseas controlled drug industry as a second main business [8][9] - The company reported a revenue of 905 million yuan for 2024, a year-on-year increase of 10.69%, and a net profit attributable to shareholders of 160 million yuan, up 59.77% year-on-year [9] - The overseas controlled drug business in Australia is focused on treating chronic pain, cancer pain, pediatric epilepsy, and assisting in mental illness treatment [9] Group 3 - As of August 13, Yongji Co., Ltd.'s stock price closed at 10.88 yuan per share, an increase of 3.82% [10]